Mera Pharmaceuticals (MRPI) Stock Statistics & Valuation Metrics
Total Valuation
Mera Pharmaceuticals has a market cap or net worth of $537.00. The enterprise value is $279.00M.
- Market Cap
- $537.00
- Enterprise Value
- $279.00M
Share Statistics
Mera Pharmaceuticals has 536,654,050 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 536,654,050
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Mera Pharmaceuticals’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 18.75%.
- Return on Equity (ROE)
- 0.19
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 18.75%
- Return on Capital Employed (ROCE)
- 0.19
- Revenue Per Employee
- 0
- Profits Per Employee
- ―
- Employee Count
- 74
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, Mera Pharmaceuticals had revenue of 0 and earned ― in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- ―
- Pretax Income
- ―
- Net Income
- ―
- EBITDA
- 0
- Earnings Per Share (EPS)
- 0.00
Stock Price Statistics
- Beta
- 115.67
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
- Current Ratio
- ―
- Quick Ratio
- ―
- Debt to Market Cap
- ―
- Net Debt to EBITDA
- 0.00
- Interest Coverage Ratio
- ―
Taxes
In the past 12 months, Mera Pharmaceuticals has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- ―
Analyst Forecast
The average price target for Mera Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
